ASEP Medical Holdings Forum: Community User: Rehberger

Es geht wieder aufwärts. Auch wird wieder für ASEP geworben

https://www.boerse-express.com/news/articles/asep-medical-aktie-fokus-sepsis-diagnostik-868410

https://www.ad-hoc-news.de/boerse/news/ueberblick/asep-medical-aktie-strategischer-umbau/68618944

https://asepmedical.com/wp-content/uploads/2026/02/Asep-NR-Heinzl-Appointed-Interim-CEO_022726_FINAL.pdf ..

ASEP MEDICAL HOLDINGS INC. ANNOUNCES LEADERSHIP TRANSITION https://www.stockwatch.com/News/Item/Z-C!ASEP-3787479/C/ASEP Dr. Robert Hancock has stepped down from his roles as chief executive officer and chairman of the board of Asep Medical Holdings Inc. to focus more directly on advancing the company's scientific initiatives.

https://www.newswire.ca/news-releases/canadian-investment-regulatory-organization-trade-resumption-asep-819172610.html Wiederaufnahme des Handels .. Neuigkeiten bereitgestellt von Kanadische Investmentaufsichtsbehörde (CIRO) – Aussetzungen/Wiederaufnahmen  18. Dezember 2025, 10:46 Uhr ET VANCOUVER, BC, 18. Dezember 2025 /CNW/  Der Handel wird wieder aufgenommen  .. ASEP Medical Holdings Inc. ... CSE-Symbol: ASEP ... Wiederaufnahme (ET): 11:00 Uhr

https://www.ad-hoc-news.de/boerse/news/ueberblick/asep-medical-aktie-handel-wiederaufgenommen/68423294

2025-12-16 14:53 ET - News Release https://www.stockwatch.com/News/Item/Z-C!ASEP-3766169/C/ASEP ASEP MEDICAL HOLDINGS ANNOUNCES REVOCATION OF FAILURE-TO-FILE CEASE TRADE ORDER ASEP Medical Holdings Inc.'s principal regulator, the British Columbia Securities Commission (BCSC), has issued a revocation order lifting the failure-to-file cease trade order (FFCTO) previously imposed on the company. The FFCTO was originally issued on May 6, 2025, as a result of the company's delay in filing its annual audited financial statements for the fiscal year ended Dec. 31, 2024, along with the accompanying management discussion and analysis and related certifications within the prescribed time period under applicable securities regulations. During the period in which the FFCTO was in effect, the company continued to operate its core business activities; however, trading in the company's securities was temporarily restricted. The revocation restores normal trading activity. ASEP Medical remains committed to maintaining strong corporate governance practices and timely financial reporting. With the FFCTO now revoked pursuant to National Policy 11-207, Failure-to-File Cease Trade Orders and Revocations in Multiple Jurisdictions, the company will continue to advance its strategic initiatives, including the further development and commercialization of its sepsis diagnostic (SepsetER) and anti-biofilm peptide technology platforms. The company appreciates the patience and continued support of its shareholders and stakeholders throughout this process. ...